Top Story

Preventable risk factors related to half of CV deaths in US adults

June 30, 2015

Preventable risk factors accounted for half of CV deaths in U.S. adults aged 45 to 79 years from 2009 to 2010, according to an analysis published in the Annals of Internal Medicine.

Researchers determined that approximately half of CV deaths could be prevented if five major risk factors — high cholesterol, diabetes, hypertension, obesity and smoking — were eliminated. In addition, if all states achieved the risk-factor levels of the best-performing states, slightly less than 10% of CV deaths could be prevented, the researchers concluded.

Jennifer Sumner In the Journals

Trauma, PTSD may be risk factors for cardiovascular disease among women

June 29, 2015
Data from the Nurses’ Health Study II indicate that female nurses who experienced trauma and elevated PTSD symptoms were more likely to develop cardiovascular…
In the Journals

Guideline update recommends stent-retrieval devices to treat certain patients with stroke

June 29, 2015
The American Heart Association and American Stroke Association published a guideline update on early management of patients with acute ischemic stroke, now recommending…
In the Journals

Rates of insurance coverage increase due to same-sex marriage laws

June 29, 2015
Marriage equality laws were associated with increases in employer-sponsored health insurance and reductions in state-funded Medicaid assistance for both men and women in…
Frederick A. Masoudi, MD, MSPH, FACC In the Journals

Societies release recommendations for implantation of percutaneous LAA occlusion devices

June 29, 2015
Percutaneous left atrial appendage occlusion devices are intended to reduce risk for stroke in patients with atrial fibrillation who are unable or unwilling to adhere to…
More News Headlines »
CME
Antiplatelet Agents in ACS Distinguishing Characteristics Safety and Efficacy

Antiplatelet Agents in ACS: Distinguishing Characteristics, Safety, and Efficacy

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
Meeting News Coverage Video
VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

June 28, 2015
NEW ORLEANS – Joseph Ho, PharmD, clinical pharmacist with Ochsner Baptist Medical Center in New Orleans…
More »
Antiplatelet Therapy in ACS and PCI

Antiplatelet Therapy in ACS and PCI

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
morganatic-roan